| Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study KM Hastie, H Li, D Bedinger, SL Schendel, SM Dennison, K Li, ... Science 374 (6566), 472-478, 2021 | 268 | 2021 |
| Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice HY Li, JF Han, CF Qin, R Chen Vaccine 31 (32), 3281-3287, 2013 | 96 | 2013 |
| Development of therapeutics for treatment of Ebola virus infection H Li, T Ying, F Yu, L Lu, S Jiang Microbes and infection 17 (2), 109-117, 2015 | 65 | 2015 |
| Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections T Ying, H Li, L Lu, DS Dimitrov, S Jiang Microbes and infection 17 (2), 142-148, 2015 | 64 | 2015 |
| Advancements in developing strategies for sterilizing and functional HIV cures W Xu, H Li, Q Wang, C Hua, H Zhang, W Li, S Jiang, L Lu BioMed research international 2017 (1), 6096134, 2017 | 59 | 2017 |
| Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice H Zhao, HY Li, JF Han, YQ Deng, SY Zhu, XF Li, HQ Yang, YX Li, Y Zhang, ... Scientific reports 5 (1), 7878, 2015 | 54 | 2015 |
| Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice H Zhao, HY Li, JF Han, YQ Deng, YX Li, SY Zhu, YL He, ED Qin, R Chen, ... Applied microbiology and biotechnology 97, 10445-10452, 2013 | 47 | 2013 |
| A randomized open-label clinical trial of an anti-HPV biological dressing (JB01-BD) administered intravaginally to treat high-risk HPV infection X Guo, L Qiu, Y Wang, Y Wang, Q Wang, L Song, Y Li, K Huang, X Du, ... Microbes and Infection 18 (2), 148-152, 2016 | 30 | 2016 |
| Crystal structures of yeast-produced enterovirus 71 and enterovirus 71/coxsackievirus A16 chimeric virus-like particles provide the structural basis for novel vaccine design … K Lyu, YL He, HY Li, R Chen Journal of Virology 89 (12), 6196-6208, 2015 | 29 | 2015 |
| Chemically modified human serum albumin potently blocks entry of Ebola pseudoviruses and viruslike particles H Li, F Yu, S Xia, Y Yu, Q Wang, M Lv, Y Wang, S Jiang, L Lu Antimicrobial Agents and Chemotherapy 61 (4), 10.1128/aac. 02168-16, 2017 | 22 | 2017 |
| Nonneutralizing antibodies induced by the HIV-1 gp41 NHR domain gain neutralizing activity in the presence of the HIV fusion inhibitor enfuvirtide: a potential therapeutic … Q Wang, W Bi, X Zhu, H Li, Q Qi, F Yu, L Lu, S Jiang Journal of virology 89 (13), 6960-6964, 2015 | 20 | 2015 |
| Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries TZ Yuan, P Garg, L Wang, JR Willis, E Kwan, AGL Hernandez, E Tuscano, ... MAbs 14 (1), 2002236, 2022 | 19 | 2022 |
| Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies AS Enriquez, TK Buck, H Li, MJ Norris, A Moon-Walker, MA Zandonatti, ... Cell reports 39 (8), 2022 | 17 | 2022 |
| Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium HM Callaway, KM Hastie, SL Schendel, H Li, X Yu, J Shek, T Buck, S Hui, ... Cell reports 42 (1), 2023 | 16 | 2023 |
| A cocktail of protective antibodies subverts the dense glycan shield of Lassa virus H Li, T Buck, M Zandonatti, J Yin, A Moon-Walker, J Fang, A Koval, ... Science translational medicine 14 (668), eabq0991, 2022 | 16 | 2022 |
| Neutralizing antibodies against Lassa virus lineage I TK Buck, AS Enriquez, SL Schendel, MA Zandonatti, SS Harkins, H Li, ... MBio 13 (4), e01278-22, 2022 | 13 | 2022 |
| Structural basis for antibody-mediated neutralization of lymphocytic choriomeningitis virus A Moon-Walker, Z Zhang, DS Zyla, TK Buck, H Li, RD Avalos, ... Cell chemical biology 30 (4), 403-411. e4, 2023 | 6 | 2023 |
| Coronavirus immunotherapeutic consortium database J Mahita, B Ha, A Gambiez, SL Schendel, H Li, KM Hastie, SM Dennison, ... Database 2023, baac112, 2023 | 6 | 2023 |
| Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants K Li, RHC Huntwork, GQ Horn, M Abraha, KM Hastie, H Li, V Rayaprolu, ... Journal of Virology 97 (12), e01070-23, 2023 | | 2023 |
| Engineered arenavirus glycoprotein compositions and methods of use thereof EO Saphire, K Hastie, H Li US Patent App. 18/021,792, 2023 | | 2023 |
Shibo JiangFudan University在 fudan.edu.cn 的电子邮件经过验证
